• 1. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 2. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives

Introduction to 2'-(Trifluoromethyl)-2,4'-bipyrimidine (CAS No: 1269292-51-4)

2'-(Trifluoromethyl)-2,4'-bipyrimidine, identified by the Chemical Abstracts Service Number (CAS No) 1269292-51-4, is a specialized heterocyclic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research. This bipyrimidine derivative features a trifluoromethyl substituent at the 2-position, which imparts unique electronic and steric properties to the molecule. The presence of two pyrimidine rings linked at the 2 and 4 positions enhances its potential as a building block for more complex molecular architectures.

The trifluoromethyl group is a key structural feature that influences the compound's reactivity, metabolic stability, and biological activity. In medicinal chemistry, trifluoromethyl groups are frequently incorporated into drug candidates due to their ability to improve lipophilicity, binding affinity, and resistance to metabolic degradation. The bipyrimidine core itself is a versatile scaffold that has been explored in various therapeutic areas, including antiviral, anticancer, and antimicrobial applications.

Recent advancements in synthetic methodologies have enabled the efficient preparation of 2'-(Trifluoromethyl)-2,4'-bipyrimidine, making it more accessible for academic and industrial research. The synthesis typically involves multi-step reactions starting from commercially available precursors, often employing palladium-catalyzed cross-coupling reactions to construct the bipyrimidine linkage. The introduction of the trifluoromethyl group can be achieved through fluorination or metal-halogen exchange strategies, providing chemists with multiple routes to functionalize this core structure.

In the realm of drug discovery, 2'-(Trifluoromethyl)-2,4'-bipyrimidine has been investigated as a precursor for kinase inhibitors and other small-molecule therapeutics. Kinases play a crucial role in signal transduction pathways and are often targeted in oncology and inflammatory disease treatments. The bipyrimidine scaffold can mimic ATP binding pockets in kinases, while the electron-withdrawing nature of the trifluoromethyl group can enhance interactions with key residues in the active site. Several research groups have reported novel kinase inhibitors derived from this compound, demonstrating its potential as a pharmacophore.

Moreover, the agrochemical industry has shown interest in bipyrimidine derivatives due to their herbicidal and fungicidal properties. The structural motif is found in several commercial crop protection agents, where modifications at different positions of the bipyrimidine ring contribute to their efficacy against various pests and pathogens. The incorporation of a trifluoromethyl group may further enhance the bioactivity of these compounds by improving their physicochemical properties.

The biological activity of 2'-(Trifluoromethyl)-2,4'-bipyrimidine has been explored in preclinical studies aimed at understanding its potential therapeutic applications. Initial assays have suggested that this compound exhibits inhibitory effects on certain enzymes and cellular pathways relevant to human diseases. However, further research is required to fully elucidate its mechanism of action and optimize its pharmacological profile. In vitro studies have demonstrated interactions with enzymes such as thymidylate synthase (TS), which is involved in DNA synthesis and repair.

Computational chemistry approaches have also been employed to study the molecular interactions of 2'-(Trifluoromethyl)-2,4'-bipyrimidine with biological targets. Molecular docking simulations have helped identify key residues in protein binding pockets that contribute to its affinity for specific enzymes. These insights have guided medicinal chemists in designing analogs with improved potency and selectivity. Additionally, quantum mechanical calculations have provided valuable information about the electronic structure of the compound, which is essential for understanding its reactivity and stability.

The synthesis and application of 2'-(Trifluoromethyl)-2,4'-bipyrimidine also highlight advancements in green chemistry principles. Recent methodologies focus on reducing waste generation and improving atom economy during synthetic processes. Catalytic systems that minimize hazardous byproducts have been developed, aligning with sustainable practices in chemical manufacturing. Such innovations are crucial for ensuring that pharmaceutical intermediates like this compound are produced efficiently while minimizing environmental impact.

Future directions in research may explore derivatization strategies to expand the chemical space around this core scaffold. Functionalization at other positions on the bipyrimidine ring or introduction of additional substituents could lead to novel compounds with enhanced biological activity or improved pharmacokinetic profiles. Collaborative efforts between synthetic chemists and biologists will be essential to translate these findings into tangible therapeutic or agrochemical applications.

In conclusion,2'-(Trifluoromethyl)-2,4'-bipyrimidine (CAS No: 1269292-51-4) represents a promising compound with diverse potential applications in pharmaceuticals and agrochemicals. Its unique structural features—particularly the presence of a trifluoromethyl group—make it an attractive scaffold for drug discovery efforts aimed at developing next-generation therapeutics. As research continues to uncover new synthetic methods and biological activities associated with this molecule,it is poised to play an increasingly important role in addressing unmet medical needs.

• 91474-18-9(Pyrimidine, 4-methyl-2,6-bis(trifluoromethyl)-)
• 1017464-05-9(4-Methyl-2-(trifluoromethyl)pyrimidine)
• 149771-18-6(2-Methyl-4-(trifluoromethyl)pyrimidine)
• 1269293-96-0(4-(Pyridin-2-yl)-2-(trifluoromethyl)pyrimidine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)